Gelonghui October 29th | luoxin pharmaceuticals group stock (002793.SZ) released the third quarter report of 2024, the company achieved revenue of 1.881 billion yuan in the first three quarters, a year-on-year increase of 2.98%; with a net loss of 0.265 billion yuan. Among them, the third quarter achieved revenue of 0.622 billion yuan, a year-on-year increase of 8.87%; with a net loss of 0.177 billion yuan.
罗欣药业(002793.SZ)前三季度营收18.81亿元 同比增长2.98%
luoxin pharmaceuticals group stock (002793.SZ) achieved revenue of 1.881 billion yuan in the first three quarters, a year-on-year increase of 2.98%.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated